Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors / Wiley series in drug discovery and development (PDF)
Drug Discovery and Development
(Sprache: Englisch)
Many researchers believe that GSK-3 and its inhibitors could lead to effective treatments for neurogenerative disorders, type II diabetes, depression and bipolar disorder, and some forms of cancer. This book provides a thorough introduction to GSK-3,...
sofort als Download lieferbar
eBook (pdf)
158.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors / Wiley series in drug discovery and development (PDF)“
Many researchers believe that GSK-3 and its inhibitors could lead to effective treatments for neurogenerative disorders, type II diabetes, depression and bipolar disorder, and some forms of cancer. This book provides a thorough introduction to GSK-3, presents up-to-date information, and mentions the birth of several chemical families of GSK-3 inhibitors with varying selectivity. It's a great reference for researchers in drug design and development.
Inhaltsverzeichnis zu „Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors / Wiley series in drug discovery and development (PDF)“
Foreword: The Origins of GSK-3. Preface. Acknowledgments. Contributors. Abbreviations. PART I: CELLULAR FUNCTIONS OF GSK-3. 1. Glycogen Synthase Kinase-3 - an Introductory Synopsis . 2. Glycogen-Synthase-Kinase-beta (GSK-3beta) a Key Signaling Enzyme: A Developmental Neurobiological Perspective. 3. Role of GSK3/Shaggy in neuronal cell biology. 4. The Crystal Structures of Glycogen Synthase Kinase 3. 5. Kinase-Kinase and Site-Site Interactions in the Phosphorylation of Tau by GSK-3. PART II: GSK3 AS A THERAPEUTIC TARGET IN HUMAN PATHOLOGY. 6. GSK-3, a Key Player in Alzheimer's Disease. 7. Glycogen Synthase Kinase-3: A Target for Novel Mood Disorder Treatments. 8. GSK3 and Stem Cells. 9. Glycogen Synthase Kinase-3: role in Neurodegeneration and Neuroprotection. 10. Protein Kinase Inhibitors. Assay Development. 11. Animal Models with Modified Expression of GSK-3 for the Study of Its Physiology and of Its Implications in Human Pathologies. PART III: GSK-3 INHIBITORS: DEVELOPMENT AND THERAPEUTIC POTENTIAL. 12. Lithium, the Seminal GSK3 Inhibitor. 13. Inhibition of GSK3 as Therapeutic Strategy in Disease: Efficacy of AR-A014418. 14. TDZD's: Selective And ATP Non Competitive Glycogen Synthase Kinase-3 Inhibitors. 15. 3-Amino Pyrazoles as Potent and Selective Glycogen Synthase (GSK-3) Inhibitors. 16. Marine compounds as a new source for Glycogen Synthase Kinase-3 Inhibitors. Index.
Autoren-Porträt
ANA MARTINEZ is the Research and Development Director forNeuroPharma. She has been and still is an active researcher in the
design and synthesis of GSK-3 inhibitors.
ANA CASTRO is the Medicinal Chemistry Director of
NeuroPharma. She was formerly a tenured scientist at the Medicinal
Chemistry Institute.
MIGUEL MEDINA is the Drug Discovery Director at
NeuroPharma. He was formerly an instructor at the Brigham and
Women's Hospital and the Harvard Medical School.
Bibliographische Angaben
- 2006, 1. Auflage, 384 Seiten, Englisch
- Herausgegeben: Ana Martinez, Ana Castro, Miguel Medina
- Verlag: John Wiley & Sons
- ISBN-10: 0470052155
- ISBN-13: 9780470052150
- Erscheinungsdatum: 11.10.2006
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 10 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors / Wiley series in drug discovery and development"
0 Gebrauchte Artikel zu „Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors / Wiley series in drug discovery and development“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors / Wiley series in drug discovery and development".
Kommentar verfassen